T Maass
Papers
1
Total Citations
54
H-Index
1
About
T. Maass is a leading figure in radiation oncology, with a primary focus on stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer (NSCLC). Their most influential work, the 2017 "Planning benchmark study for SBRT of early stage NSCLC," has garnered 54 citations, establishing a critical standard for treatment planning and dosimetric consistency across institutions. This benchmark study systematically evaluated variations in SBRT planning, highlighting best practices that directly improve tumor control and reduce toxicity. Maass's contributions have shaped clinical protocols, ensuring more reproducible and effective radiation delivery for lung cancer patients. Their research bridges the gap between technical precision and patient outcomes, making them a key voice in advancing SBRT methodology. With a career dedicated to refining radiotherapy techniques, Maass continues to influence how early-stage NSCLC is treated, offering a foundation for future innovations in hypofractionated and adaptive radiation therapy. Their work remains essential reading for clinicians and researchers striving to optimize SBRT in lung cancer management.
Research Focus
Key Achievements
Top Papers
- 1Planning benchmark study for SBRT of early stage NSCLC54 citations · 2017